| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-016717 |
| cik | 1538495 |
| name | EARTH SCIENCE TECH, INC. |
| sic | 2834 |
| countryba | US |
| stprba | FL |
| cityba | MIAMI |
| zipba | 33156 |
| bas1 | 8950 SW 74TH CT |
| bas2 | SUITE 101 |
| baph | (786) 375-7281 |
| countryma | US |
| stprma | FL |
| cityma | MIAMI |
| zipma | 33156 |
| mas1 | 8950 SW 74TH CT |
| mas2 | SUITE 101 |
| countryinc | US |
| stprinc | FL |
| ein | 454267181 |
| former | ULTIMATE NOVELTY SPORTS INC. |
| changed | 20111230 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0331 |
| form | 10-K |
| period | 20250331 |
| fy | 2024 |
| fp | FY |
| filed | 20250627 |
| accepted | 2025-06-26 17:58:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-k_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-016717 | 20240331 | Accounts Receivable Net Current | 235423.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Accounts Receivable Net Current | 129064.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Assets Current | 1258234.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Deposits Assets Current | 9352.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Income Tax Expense Benefit | 116776.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Deposits Assets | 9352.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20250331 | Interest Income Other | 17.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Liabilities Current | 3146305.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Liabilities Noncurrent | 69305.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Cash Provided By Used In Investing Activities | -26520.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-016717 | 20250331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20250331 | Net Income Loss | 3253635.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20250331 | Operating Lease Liability Current | 121851.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Payments For Repurchase Of Common Stock | 1465890.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Payments Of Debt Issuance Costs | 450217.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Proceeds From Issuance Of Common Stock | 110331.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Proceeds From Sale Of Short Term Investments | 3601738.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Rent Expense | USD | 4 | 0001641172-25-016717 | ||||
| 0001641172-25-016717 | 20230331 | Shares Outstanding | 1000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20240331 | Shares Outstanding | 309981819.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Shares Outstanding | 295347903.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | -29655076.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | 18864.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | 172800.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased During Period Shares | 14633916.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Treasury Stock Common Shares | 1045296.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-016717 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 303521458.0000 | shares | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Bank Charges | 422970.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1473228.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Shares Authorized | 350000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Cost Of Goods And Services Sold | 4125139.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Deposits Assets Current | 338108.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Depreciation And Amortization | 151655.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 3370410.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Initial Recognition Of Right Of Use Asset | 100294.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Insurance Commissions | 5363.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Intangible Assets Net Excluding Goodwill | 28441.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Interest Paid Net | 21189.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Liabilities And Stockholders Equity | 3881336.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Liabilities And Stockholders Equity | 7066721.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Long Term Notes And Loans | 60559.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Marketing And Advertising Expense | 25283.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20240331 | Notes And Loans Payable Current | 30592.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Other Accounts Payable And Accrued Liabilities | 2322022.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Payments For Repurchase Of Common Stock | 178000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Preferred Stock Shares Issued | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Prepaid Expense Current | 20730.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Retained Earnings Accumulated Deficit | -29655076.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 11953635.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; | ||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3090251.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Non Core; Product Or Service= Shipping Income; | ||
| 0001641172-25-016717 | 20250331 | Selling General And Administrative Expense | 4154838.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 371594.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 13406.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | 186404.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001641172-25-016717 | 20240331 | Unrealized Gain Loss On Investments | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Utilities Expense | 15368.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20250331 | Accounts Payable Current | 492352.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Additional Paid In Capital | 31593399.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 697721.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Issued On Conversion Of Notes Payable | USD | 4 | 0001641172-25-016717 | ||||
| 0001641172-25-016717 | 20240331 | Common Stock Shares Issued | 309981819.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Earnings Per Share Diluted | 0.0030 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Equity Securities Fv Ni | 645438.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Gross Profit | 24300136.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 1428932.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Operating Lease Liability | -73870.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 20729.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Interest Income Expense Net | -67207.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Investment Income Dividend | 9123.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Legal Fees | 305932.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Liabilities Current | 1486522.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Liabilities Noncurrent | 145509.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Operating Lease Right Of Use Asset | 156517.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Other Expenses | 6542.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Property Plant And Equipment Net | 1384110.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 11953635.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 28831.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; Product Or Service= Sale Of Pharmaceutical Products Peaks; | ||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 30027373.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; | ||
| 0001641172-25-016717 | 20240331 | Short Term Borrowings | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | 282612.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | 31480143.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 300000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | 300.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20250331 | Unrealized Gain Loss On Investments | -365661.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Accounts Payable Current | 530724.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Assets | 3881336.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Common Stock Shares Outstanding | 309981819.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Cost Of Goods And Services Sold | 8817488.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Depreciation And Amortization | 149749.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Depreciation Depletion And Amortization | 151654.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Gain On Sale Of Investments | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20250331 | Goodwill | 125136.0000 | USD | 0 | us-gaap/2024 | Business Acquisition= Las Villas Health Care L L C; Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-016717 | 20250331 | Goodwill | 133442.0000 | USD | 0 | us-gaap/2024 | Business Acquisition= Magnefuse L L C; Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-016717 | 20240331 | Income Tax Expense Benefit | 13003.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 868176.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Initial Recognition Of Right Of Use Asset | USD | 4 | 0001641172-25-016717 | ||||
| 0001641172-25-016717 | 20250331 | Insurance Commissions | 180281.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Liabilities | 1632031.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Liabilities | 3215610.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Marketing And Advertising Expense | 836860.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | 812139.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-016717 | 20240331 | Operating Lease Liability Current | 70487.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Operating Lease Liability Noncurrent | 84950.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Operating Lease Liability Noncurrent | 37878.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Other Expenses | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Preferred Stock Shares Outstanding | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Proceeds From Issuance Of Debt | 179488.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Purchases Of Property And Equipment And Intangibles | 753165.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 11953635.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Non Core; | ||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 534649.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; Product Or Service= Sale Of Pharmaceutical Products Peaks; | ||
| 0001641172-25-016717 | 20250331 | Salaries And Wages | 14115643.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20230331 | Shares Outstanding | 282611083.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Shares New Issues | 18864423.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 385000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased During Period Shares | 1465425.0000 | shares | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Treasury Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 309687386.0000 | shares | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Goodwill | 2302792.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Gain On Sale Of Investments | 300162.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Assets | 7066721.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Bank Charges | 1066577.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Cash | 697721.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Common Stock Shares Authorized | 350000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Shares Issued | 295347903.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Shares Outstanding | 294302607.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Earnings Per Share Basic | 0.0110 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Inventories | 305478.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20250331 | Intangible Assets Net Excluding Goodwill | 96885.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Interest Income Other | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Legal Fees | 1774182.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Long Term Notes And Loans | 31427.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Net Cash Provided By Used In Financing Activities | -1715533.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Net Cash Provided By Used In Investing Activities | -1881350.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Net Cash Provided By Used In Operating Activities | 4372390.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Notes And Loans Payable Current | 30592.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Operating Expenses | 20852178.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Other Accounts Payable And Accrued Liabilities | 854719.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Payments Of Debt Issuance Costs | 429131.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Preferred Stock Shares Issued | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Proceeds From Issuance Of Debt | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Proceeds From Sale Of Short Term Investments | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Property Plant And Equipment Net | 135352.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Rent Expense | 10797.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Shares Outstanding | 1000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | -30467215.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | 31593399.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | 295347.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | -186404.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | 14635.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Repurchased During Period Shares | 5200000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Additional Paid In Capital | 31480143.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20230331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 35756.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 661835.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Common Stock Issued On Conversion Of Notes Payable | 385000.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Depreciation Depletion And Amortization | 149749.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Earnings Per Share Diluted | 0.0110 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 825142.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Income Taxes Paid Net | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Increase Decrease In Accounts Receivable | 235423.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Inventories | 188200.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Interest Paid Net | 67207.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Inventory Net | 503938.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Investment Income Dividend | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20250331 | Payments To Acquire Other Productive Assets | 417248.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Preferred Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Preferred Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20250331 | Retained Earnings Accumulated Deficit | -27738975.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | USD | 4 | us-gaap/2024 | Core And Non Core Status= Non Core; Product Or Service= Shipping Income; | |||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 33117624.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Non Core; | ||
| 0001641172-25-016717 | 20250331 | Share Based Compensation | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Shares Outstanding | 309981819.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Short Term Borrowings | 179488.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | 1119535.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | 113256.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | 186404.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Assets Current | 3110505.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Cash | 1473228.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Common Stock Value | 309982.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Common Stock Value | 295348.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Earnings Per Share Basic | 0.0030 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Equity Securities Fv Ni | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Gross Profit | 7828496.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Operating Lease Liability | -96003.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Interest Income Expense Net | -21189.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Inventory Net | 315738.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Net Income Loss | 3253635.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-016717 | 20240331 | Operating Expenses | 6936147.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Operating Lease Right Of Use Asset | 172429.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Payments To Acquire Equity Securities Fv Ni | USD | 4 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Preferred Stock Shares Outstanding | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Purchases Of Property And Equipment And Intangibles | 26520.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 11924804.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; Product Or Service= Sale Of Pharmaceutical Products Rx Compound; | ||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 33117624.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 29492724.0000 | USD | 4 | us-gaap/2024 | Core And Non Core Status= Core; Product Or Service= Sale Of Pharmaceutical Products Rx Compound; | ||
| 0001641172-25-016717 | 20240331 | Salaries And Wages | 4358917.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Share Based Compensation | 300.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20230331 | Stockholders Equity | 31303138.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | 2249305.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Stockholders Equity | 309982.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value Share Based Compensation | 300.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | 5200.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | 1465425.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | USD | 4 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value Acquired Par Value Method | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-016717 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 303521458.0000 | shares | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 309687386.0000 | shares | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 775507.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Goodwill | 2302792.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Income Taxes Paid Net | 28319.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Accounts Receivable | -106359.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Increase Decrease In Deposits Assets | 328756.0000 | USD | 4 | 0001641172-25-016717 | |||
| 0001641172-25-016717 | 20240331 | Net Cash Provided By Used In Financing Activities | -517886.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Cash Provided By Used In Operating Activities | 1206241.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-016717 | 20240331 | Net Income Loss | 812139.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20250331 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Payments To Acquire Equity Securities Fv Ni | 4312675.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Prepaid Expense Current | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-016717 | 20240331 | Selling General And Administrative Expense | 166976.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Shares Outstanding | 1000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | 3851111.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Stockholders Equity | -27738975.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 13406313.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | 110331.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Stock Issued During Period Value New Issues | 91467.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | 178000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20240331 | Stock Repurchased And Retired During Period Value | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | |||
| 0001641172-25-016717 | 20250331 | Stock Repurchased And Retired During Period Value | 1337534.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-016717 | 20250331 | Treasury Stock Value | 186404.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-016717 | 20250331 | Utilities Expense | 40392.0000 | USD | 4 | 0001641172-25-016717 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Purchases Of Property And Equipment And Intangibles | 0001641172-25-016717 | 1 | 0 | monetary | D | C | PurchasesOfPropertyAndEquipmentAndIntangibles | Purchases of property and equipment and intangibles. |
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Investment Income Dividend | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Dividend | Amount of dividend income on nonoperating securities. |
| Payments To Acquire Equity Securities Fv Ni | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Equity Securities, FV-NI | Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. |
| Equity Securities Fv Ni | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Current | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Marketing And Advertising Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Marketing and Advertising Expense | The total expense recognized in the period for promotion, public relations, and brand or product advertising. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Issued On Conversion Of Notes Payable | 0001641172-25-016717 | 1 | 0 | monetary | D | C | Common stock issued on conversion of notes payable | Common stock issued on conversion of notes payable. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Payments Of Debt Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Debt Issuance Costs | The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Insurance Commissions | us-gaap/2024 | 0 | 0 | monetary | D | D | Insurance Commissions | The expense incurred by an insurance company to persons or entities for generating or placing insurance or investment contracts with the company, usually determined as a percentage of policy or contract premiums. Excludes advances or draws to be applied against commissions earned. |
| Long Term Notes And Loans | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes and Loans, Noncurrent | Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accounts Payable and Accrued Liabilities | Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Initial Recognition Of Right Of Use Asset | 0001641172-25-016717 | 1 | 0 | monetary | D | C | Initial recognition of right of use asset | Initial recognition of right of use asset |
| Rent Expense | 0001641172-25-016717 | 1 | 0 | monetary | D | D | Rent expense | Rent expense. |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Other Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Expenses | Amount of expense classified as other. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Issuance Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Debt | The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. |
| Salaries And Wages | us-gaap/2024 | 0 | 0 | monetary | D | D | Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold | Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Treasury Stock Value Acquired Par Value Method | us-gaap/2024 | 0 | 0 | monetary | D | D | Treasury Stock, Value, Acquired, Par Value Method | Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method. |
| Unrealized Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Sale Of Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Short-Term Investments | The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Stock Repurchased And Retired During Period Value | us-gaap/2024 | 0 | 0 | monetary | D | D | Stock Repurchased and Retired During Period, Value | Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). |
| Deposits Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Deposits Assets, Current | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. |
| Gain On Sale Of Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain on Sale of Investments | The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Interest Income Expense Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Operating | Amount of interest income (expense) classified as operating. |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Short Term Borrowings | us-gaap/2024 | 0 | 0 | monetary | I | C | Short-Term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. |
| Stock Repurchased During Period Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Repurchased During Period, Shares | Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Utilities Expense | 0001641172-25-016717 | 1 | 0 | monetary | D | D | Utilities | Utilities expense. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Income Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income, Other | Amount of interest income earned from interest bearing assets classified as other. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Notes And Loans Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes and Loans Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer. |
| Payments For Repurchase Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Payments To Acquire Other Productive Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Other Productive Assets | Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Bank Charges | 0001641172-25-016717 | 1 | 0 | monetary | D | D | Bank charges | Bank charges. |
| Increase Decrease In Deposits Assets | 0001641172-25-016717 | 1 | 0 | monetary | D | C | IncreaseDecreaseInDepositsAssets | Increase decrease in deposits assets. |
| Legal Fees | us-gaap/2024 | 0 | 0 | monetary | D | D | Legal Fees | The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-016717 | 2 | 20 | BS | 0 | H | Short Term Borrowings | us-gaap/2024 | Short-term business loans | 0 |
| 0001641172-25-016717 | 2 | 3 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001641172-25-016717 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts Receivable | 0 |
| 0001641172-25-016717 | 2 | 5 | BS | 0 | H | Equity Securities Fv Ni | us-gaap/2024 | Equity Investments at fair value | 0 |
| 0001641172-25-016717 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0001641172-25-016717 | 2 | 7 | BS | 0 | H | Deposits Assets Current | us-gaap/2024 | Deposits | 0 |
| 0001641172-25-016717 | 2 | 8 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid Expenses | 0 |
| 0001641172-25-016717 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001641172-25-016717 | 2 | 11 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and Equipment | 0 |
| 0001641172-25-016717 | 2 | 12 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right of use asset, net | 0 |
| 0001641172-25-016717 | 2 | 13 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001641172-25-016717 | 2 | 14 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001641172-25-016717 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001641172-25-016717 | 2 | 17 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts Payable | 0 |
| 0001641172-25-016717 | 2 | 18 | BS | 0 | H | Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accrued Expenses and other payables | 0 |
| 0001641172-25-016717 | 2 | 19 | BS | 0 | H | Notes And Loans Payable Current | us-gaap/2024 | Current portion of loans & obligations | 0 |
| 0001641172-25-016717 | 2 | 21 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease obligations | 0 |
| 0001641172-25-016717 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001641172-25-016717 | 2 | 24 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease Liability | 0 |
| 0001641172-25-016717 | 2 | 25 | BS | 0 | H | Long Term Notes And Loans | us-gaap/2024 | Loans and Obligations | 0 |
| 0001641172-25-016717 | 2 | 26 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total Long-Term Liabilities | 0 |
| 0001641172-25-016717 | 2 | 27 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001641172-25-016717 | 2 | 28 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitment and Contingencies (Note 12) | 0 |
| 0001641172-25-016717 | 2 | 30 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 shares issued and outstanding as of March 31, 2025 and, 2024 | 0 |
| 0001641172-25-016717 | 2 | 31 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, par value $0.001 per share, 350,000,000 shares authorized; 295,347,903 and 309,981,819 shares issued and 294,302,607 and 309,981,819 shares outstanding as of March 31, 2025, and March 31, 2024, respectively | 0 |
| 0001641172-25-016717 | 2 | 32 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional Paid in Capital | 0 |
| 0001641172-25-016717 | 2 | 33 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated Deficit | 0 |
| 0001641172-25-016717 | 2 | 34 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury Stock, at cost (1,045,296 Shares) | 1 |
| 0001641172-25-016717 | 2 | 35 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Equity | 0 |
| 0001641172-25-016717 | 2 | 36 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND EQUITY | 0 |
| 0001641172-25-016717 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-016717 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-016717 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-016717 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-016717 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-016717 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-016717 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-016717 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-016717 | 3 | 9 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury common shares | 0 |
| 0001641172-25-016717 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Revenue | 0 |
| 0001641172-25-016717 | 4 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of Goods Sold | 0 |
| 0001641172-25-016717 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross Profit | 0 |
| 0001641172-25-016717 | 4 | 5 | IS | 0 | H | Salaries And Wages | us-gaap/2024 | Salaries Expense | 0 |
| 0001641172-25-016717 | 4 | 6 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling general and administrative expenses | 0 |
| 0001641172-25-016717 | 4 | 7 | IS | 0 | H | Bank Charges | 0001641172-25-016717 | Bank charges | 0 |
| 0001641172-25-016717 | 4 | 8 | IS | 0 | H | Marketing And Advertising Expense | us-gaap/2024 | Advertising & marketing | 0 |
| 0001641172-25-016717 | 4 | 9 | IS | 0 | H | Legal Fees | us-gaap/2024 | Legal and professional fees | 0 |
| 0001641172-25-016717 | 4 | 10 | IS | 0 | H | Insurance Commissions | us-gaap/2024 | Insurance | 0 |
| 0001641172-25-016717 | 4 | 11 | IS | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-016717 | 4 | 12 | IS | 0 | H | Utilities Expense | 0001641172-25-016717 | Utilities | 0 |
| 0001641172-25-016717 | 4 | 13 | IS | 0 | H | Rent Expense | 0001641172-25-016717 | Rent expense | 0 |
| 0001641172-25-016717 | 4 | 14 | IS | 0 | H | Other Expenses | us-gaap/2024 | Miscellaneous | 0 |
| 0001641172-25-016717 | 4 | 15 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total Expenses | 0 |
| 0001641172-25-016717 | 4 | 16 | IS | 0 | H | Investment Income Dividend | us-gaap/2024 | Dividend income | 0 |
| 0001641172-25-016717 | 4 | 17 | IS | 0 | H | Interest Income Other | us-gaap/2024 | Interest earned | 0 |
| 0001641172-25-016717 | 4 | 18 | IS | 0 | H | Gain On Sale Of Investments | us-gaap/2024 | Net realized gain on sale of investments | 0 |
| 0001641172-25-016717 | 4 | 19 | IS | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized Gain (Loss) on fair value changes of investments | 0 |
| 0001641172-25-016717 | 4 | 20 | IS | 0 | H | Interest Income Expense Net | us-gaap/2024 | Interest Expense | 0 |
| 0001641172-25-016717 | 4 | 21 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net Income before taxes | 0 |
| 0001641172-25-016717 | 4 | 22 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income Taxes | 0 |
| 0001641172-25-016717 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Income | 0 |
| 0001641172-25-016717 | 4 | 24 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Earnings per common share-Basic | 0 |
| 0001641172-25-016717 | 4 | 25 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Earnings per common share-Diluted | 0 |
| 0001641172-25-016717 | 4 | 26 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares outstanding- Basic | 0 |
| 0001641172-25-016717 | 4 | 27 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares outstanding- Diluted | 0 |
| 0001641172-25-016717 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-016717 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-016717 | 5 | 12 | EQ | 0 | H | Stock Repurchased And Retired During Period Value | us-gaap/2024 | Repurchase of common stock | 1 |
| 0001641172-25-016717 | 5 | 13 | EQ | 0 | H | Stock Repurchased During Period Shares | us-gaap/2024 | Repurchase of common stock, shares | 1 |
| 0001641172-25-016717 | 5 | 14 | EQ | 0 | H | Treasury Stock Value Acquired Par Value Method | us-gaap/2024 | Treasury Stock | 1 |
| 0001641172-25-016717 | 5 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income | 0 |
| 0001641172-25-016717 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Common stock issued for cash | 0 |
| 0001641172-25-016717 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Common stock issued for cash, shares | 0 |
| 0001641172-25-016717 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-016717 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock-based compensation, shares | 0 |
| 0001641172-25-016717 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Common stock issued for conversion of debt | 0 |
| 0001641172-25-016717 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Common stock issued for conversion of debt, shares | 0 |
| 0001641172-25-016717 | 5 | 22 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-016717 | 5 | 23 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-016717 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net Income | 0 |
| 0001641172-25-016717 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001641172-25-016717 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock based compensation | 0 |
| 0001641172-25-016717 | 6 | 6 | CF | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized loss on investments | 1 |
| 0001641172-25-016717 | 6 | 7 | CF | 0 | H | Gain On Sale Of Investments | us-gaap/2024 | Realized gain on sale of investments | 1 |
| 0001641172-25-016717 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001641172-25-016717 | 6 | 10 | CF | 0 | H | Increase Decrease In Deposits Assets | 0001641172-25-016717 | Deposits | 1 |
| 0001641172-25-016717 | 6 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-016717 | 6 | 12 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001641172-25-016717 | 6 | 13 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Lease liability, net | 0 |
| 0001641172-25-016717 | 6 | 14 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-016717 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by operating activities | 0 |
| 0001641172-25-016717 | 6 | 17 | CF | 0 | H | Purchases Of Property And Equipment And Intangibles | 0001641172-25-016717 | Purchases of property and equipment and intangibles | 1 |
| 0001641172-25-016717 | 6 | 18 | CF | 0 | H | Payments To Acquire Equity Securities Fv Ni | us-gaap/2024 | Purchase of investments | 1 |
| 0001641172-25-016717 | 6 | 19 | CF | 0 | H | Proceeds From Sale Of Short Term Investments | us-gaap/2024 | Sale of investments | 0 |
| 0001641172-25-016717 | 6 | 20 | CF | 0 | H | Payments To Acquire Other Productive Assets | us-gaap/2024 | Cash used for assets acquisition, net of cash acquired | 1 |
| 0001641172-25-016717 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001641172-25-016717 | 6 | 23 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock | 0 |
| 0001641172-25-016717 | 6 | 24 | CF | 0 | H | Payments Of Debt Issuance Costs | us-gaap/2024 | Payments on loans and obligations | 1 |
| 0001641172-25-016717 | 6 | 25 | CF | 0 | H | Proceeds From Issuance Of Debt | us-gaap/2024 | Proceeds from loan payable | 0 |
| 0001641172-25-016717 | 6 | 26 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2024 | Repurchase of common stock | 1 |
| 0001641172-25-016717 | 6 | 27 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net Cash used in financing activities | 0 |
| 0001641172-25-016717 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase in cash and cash equivalents | 0 |
| 0001641172-25-016717 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of the year | 0 |
| 0001641172-25-016717 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of the year | 0 |
| 0001641172-25-016717 | 6 | 32 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001641172-25-016717 | 6 | 33 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income taxes | 0 |
| 0001641172-25-016717 | 6 | 34 | CF | 0 | H | Initial Recognition Of Right Of Use Asset | 0001641172-25-016717 | Initial recognition of right of use asset | 0 |
| 0001641172-25-016717 | 6 | 35 | CF | 0 | H | Common Stock Issued On Conversion Of Notes Payable | 0001641172-25-016717 | Common stock issued on conversion of notes payable | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |